Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03332992 · ClinicalTrials.gov registry record · NA
Comparative Tests of Flu Vaccination Phone Messages
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 7,206
- Enrollment target
NCT03332992 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 7,206 participants.
The verdict
NCT03332992, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,206 participants
- Enrollment target
Study Summary
This project is a partnership between Emmi Solutions, a private company that delivers health promotion messages to employees of client organizations, and the University of Michigan and affiliated academic investigators. In particular, Emmi sends out pre-recorded and interactive telephone calls on behalf of their healthcare clients to promote influenza vaccination each Fall. The collaboration will design various scripts (based on established risk communication, behavior change, and behavioral economic principles) to be pre-recorded and sent out on these calls on a randomized basis (with approval by client organizations), with the number of arms to vary based on the size of each client's participant list (to ensure sufficient statistical power within each client's sample). Emmi will deliver the calls and track individual responses to questions posed during the call. Emmi will then provide a de-identified dataset to the academic research team for analysis to determine whether any scripts provided greater or lesser effects to people's their motivations to get a flu vaccination.
Interventions
- BEHAVIORAL Viral changes
- BEHAVIORAL Protect others
- BEHAVIORAL General intentions
- BEHAVIORAL Behavioral intentions
- BEHAVIORAL Accountability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,206 participants |
| Start Date | 2017-11-11 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03332992
The ClinicalTrials.gov registry entry for NCT03332992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Viral changes is the first listed.
NCT03332992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03332992 about?
NCT03332992 is a clinical study titled "Comparative Tests of Flu Vaccination Phone Messages". This project is a partnership between Emmi Solutions, a private company that delivers health promotion messages to employees of client organizations, and the University of Michigan and affiliated academic investigators. In particular, Emmi sends out pre-recorded and interactive telephone calls on be...
What is the current status of trial NCT03332992?
This trial is currently completed. It is a NA study. The enrollment target is 7,206 participants. The study started on 2017-11-11. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03332992?
The interventions under investigation include: Viral changes (BEHAVIORAL), Protect others (BEHAVIORAL), General intentions (BEHAVIORAL), Behavioral intentions (BEHAVIORAL), Accountability (BEHAVIORAL).
Who is sponsoring clinical trial NCT03332992?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.